RPI (Athawale) chief Ramdas Athawale on Tuesday said that his party was excluded from the seat-sharing talks and called it a betrayal ...

Anyone that tells you they have the investing game all figured is, well, a dope. You can tell them that cold hard reality came from Brian Sozzi at Yahoo Finance — and feel free to send me their ...

Aider is a “pair-programming” tool that can use various providers as the AI back end, including a locally running instance of ...

FDA accepted Replimune’s resubmitted Biologics License Application for RP1 combined with Bristol Myers Squibb’s Opdivo to treat advanced melanoma The agency set April 10, 2026 as the decision deadline ...

Shares of Replimune Group, Inc. (NASDAQ:REPL) are rising Monday after the clinical stage biotechnology company shared an important regulatory update. What To Know: Replimune said the U.S. Food and ...

or contact Joseph E. Levi, Esq. via email at [email protected] or call (212) 363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit ...

or contact Joseph E. Levi, Esq. via email at [email protected] or call (212) 363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit ...